Stefan Pflanz
Stefan Pflanz is a biotech veteran and has vast experience from biopharmaceutical development including Head of Cytokine Biology at Schering-Plough Research Institute, Senior Research Scientist at Gilead and most recent as Director Cancer Immunology and Immune Modulation and Excutive Director Boehringer-Ingelheim Venture Fund USA. Has served on numerous Board in biotech companies and including Actym Therapeutics Inc also a clinical stage company pioneering engineered bacteria a medicine.